All Comments by Charles Glabe

  1. Consensus features in amyloid fibrils: sheet-sheet recognition via a (polar or nonpolar) zipper structure.
  2. Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.
  3. Prefibrillar amyloid aggregates could be generic toxins in higher organisms.
  4. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.
  5. Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis.
  6. Structural differences in Abeta amyloid protofibrils and fibrils mapped by hydrogen exchange--mass spectrometry with on-line proteolytic fragmentation.
  7. Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP.
  8. Neuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer disease.
  9. Inhibition of APP trafficking by tau protein does not increase the generation of amyloid-beta peptides.
  10. Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice.
  11. Biotin-avidin interaction-based screening assay for Alzheimer's beta-peptide oligomer inhibitors.
  12. Olfaction in neurodegenerative disorder.
  13. SfN: Amyloid Oligomers—Not So Elusive, After All? Part 2
  14. <i>Drosophila</i> APP Signals Synapse Formation
  15. Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta.